Panoptykon· 7 December 2023· Meta

Algorithms of Trauma 2: 'Anxious about your health? Facebook won't let you forget'

By Dorota Głowacka, Katarzyna Szymielewicz and Piotr Sapieżyński

Case study showing Facebook's ad-delivery algorithms push distressing health/illness ads exploiting users' mental vulnerabilities; disabling 'sensitive interests' limits advertiser targeting but not Facebook's own profiling.

Ad Transparency & FraudAlgorithmic Harm & Recommender SystemsArt. 26 — Ad labelling

From the source

About this research

This original report draws on a recommender audit and a case study.

Publication
Original report · 16 pages
Research approach
recommender audit and case study

Publication details prepared by Social Media Transparency from the original source.

Executive summary

AI-generated

This summary was generated by AI from the original report to make it easier to scan and cite. It is not a substitute for the source. Read the original above.

This case study, part of Panoptykon Foundation's "Algorithms of Trauma" series, examines how Facebook's ad-delivery algorithms target users who show signs of anxiety around health and illness after they engage with related content.

The case documents that Facebook's ad-delivery system continues to surface distressing health-related ads to users who have previously shown interest in or vulnerability around such topics, in effect exploiting emotional vulnerability to keep serving related material. It notes that Meta's own "sensitive interests" control, which lets users limit third-party advertisers' ability to target them based on inferred sensitive categories, does not curb Facebook's own internal profiling and ad-delivery logic, since that setting governs advertiser targeting rather than the platform's underlying recommendation and delivery systems.

The case is presented as evidence that the opt-out privacy controls offered to users are narrower in scope than the profiling practices they are meant to address, and that platform-level ad delivery, not just third-party targeting, warrants regulatory scrutiny.

Think this summary is wrong? Contact us.